Effects of a natural extract of (-)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX plus niacin-bound chromium and Gymnema sylvestre extract on weight loss

Diabetes, Obesity and Metabolism

Volumn 6, Issue 3, 2004, Pages 171-180

  Preuss, H G ^a   Bagchi, D ^b   Bagchi, M ^b   Rao, C V S ^c   Dey, D K ^d   Satyanarayana, S ^e  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^c ASR Academy of Medical Sciences   (India)

^d UNIVERSITY OF CONNECTICUT   (United States)

^e ANDHRA UNIVERSITY   (India)

Author keywords

( ) hydroxycitric acid (Garcinia cambogia); Appetite suppression; Body mass index; Gymnema sylvestre extract; Niacinbound chromium; Serum leptin; Total cholesterol

Indexed keywords

ANOREXIGENIC AGENT; CHOLESTEROL; CHROMIUM DERIVATIVE; GLUCOSE; GYMNEMA SYLVESTRE EXTRACT; HIGH DENSITY LIPOPROTEIN; HYDROXYCITRIC ACID; INSULIN; LEPTIN; LIPID; LOW DENSITY LIPOPROTEIN; PLACEBO; PLANT EXTRACT; SUPER CITRIMAX; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; APPETITE; ARTICLE; BODY MASS; BODY WEIGHT; CENTRAL NERVOUS SYSTEM; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; FEMALE; FOOD INTAKE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; GYMNEMA SYLVESTRE; HEADACHE; HEARTBURN; HUMAN; INCREASED APPETITE; INSULIN BLOOD LEVEL; LEG CRAMP; LIPID ANALYSIS; LIPOGENESIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MENSTRUATION DISORDER; MUSCLE WEAKNESS; OBESITY; PATIENT MONITORING; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RASH; REGULATORY MECHANISM; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS; URINARY EXCRETION; WALKING; WEIGHT REDUCTION;

EID: 2342417425     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1462-8902.2004.00328.x     Document Type: Article

References (56)

1. Stunkard AJ. Current views on obesity. Am J Med 1996; 100: 230-236.
2. Jequier E. Pathways to obesity. Int J Obes Relat Metab Disord 2002; 260: S12-S17.
3. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000; 320: 1240-1243.
4. Roberts SB, McCrory MA, Saltzman E. The influence of dietary composition on energy intake and body weight. J Am Coll Nutr 2002; 21: 140S-145S.
5. Popkin BM, Paeratakul S, Zhai F, Keyou G. A review of dietary and environmental correlates of obesity with emphasis on developing countries. Obes Res 1995; 3: 145S-153S.
6. Campbell I. The obesity epidemic: Can we turn the tide? Heart 2003; 89: 35-37.
7. Morley JE. Neuropeptide regulation of appetite and weight. Endocr Rev 1987; 8: 256-287.
8. Sobal J, Stunkard AJ. Socioeconomic status and obesity: a review of the literature. Psychol Bull 1989; 105: 260-275.
9. Namnoum AB. Obesity: a disease worth treating. Female Patient 1993; 18: 33-44.
10. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1995; 1: 1311-1314.
11. Bandini LG, Schoeller DA, Cyr HN, Dietz WH. Validity of reported energy intake in obese and nonobese adolescents. Am J Clin Nutr 1990; 52: 421-425.
12. Sullivan AC, Triscari J, Cheng L. Appetite regulation by drugs and endogenous substances. Curr Concep Nutr 1983; 12: 139-167.
13. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000; 343: 1833-1838.
14. Clouatre D, Rosenbaum M. The diet and health benefits of HCA. In: A Keats Good Health Guide. 1994; 9.
15. Sergio W. A natural food, the Malabar Tamarind, may be effective in the treatment of obesity. Med Hypotheses 1988; 27: 39-40.
16. Jena BS, Jayaprakasha GK, Singh RP, Sakariah KK. Chemistry and biochemistry of (-)-hydroxycitric acid from Garcinia. J Agric Food Chem 2002; 50: 10-22.
17. Lowenstein JM. Effect of (-)-hydroxycitrate on fatty acid synthesis by rat liver in vivo. J Biol Chem 1971; 246: 629-632.
18. Sullivan AC, Triscari J, Hamilton JG, Miller ON, Wheatley VR. Effect of (-)-hydroxycitrate upon the accumulation of lipid in the rat. I. Lipogenesis. Lipids 1974; 9: 121-128.
19. Sullivan AC, Triscari J, Hamilton JG, Miller ON. Effect of (-)-hydroxycitrate upon the accumulation of lipid in the rat. II. Appetite. Lipids 1974; 9: 129-134.
20. Triscari J, Sullivan AC. Anti-obesity activity of a novel lipid synthesis inhibitor. Int J Obes 1984; 8: 227-239.
21. Leibowitz SF, Alexander JT. Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol Psychiatry 1988; 44: 851-864.
22. Casper RC. Serotonin, a major player in the regulation of feeding and affect. Biol Psychiatry 1998; 44: 795-797.
23. Ohia SE, Awe O, LeDay AM, Opere CA, Bagchi D. Effect of hydroxycitric acid on serotonin release from isolated rat brain cortex. Res Commun Mol Pathol Pharmacol 2001; 109: 210-216.
24. Crawford V, Scheckenbach R, Preuss HG. Effects of niacin-bound chromium supplementation on body composition in overweight African-American women. Diabetes Obes Metab 1999; 1: 331-337.
25. Grant KE, Chandler RM, Castle AL, Ivy JL. Chromium and exercise training: effect on obese women. Med Sci Sports Exerc 1997; 29: 992-998.
26. Preuss HG, Montamarry S, Echard B, Scheckenbach R, Bagchi D. Long term effects of chromium, grape seed extract, and zinc on various metabolic parameters in rats. Mol Cell Biochem 2001; 223: 95-102.
27. Prakash AO, Mathur S, Mathur R. Effect of feeding Gymnema sylvestre leaves on blood glucose in beryllium nitrate treated rats. J Ethnopharmacol 1986; 18: 143-146.
28. Ninomiya Y, Imoto T. Gurmarin. Inhibition of sweet taste responses in mice. Am J Physiol 1995; 268: R1019-R1025.
29. Preuss HG, Jarrell ST, Scheckenbach R, Lieberman S, Anderson RA. Comparative effects of chromium, vanadium and Gymnema sylvestre on sugar-induced blood pressure elevations in SHR. J Am Coll Nutr 1998; 17: 116-123.
30. Shanmugasundaram ERB, Rajeswari G, Baskaran K, Kumar BRR, Shanmugasundaram KR, Ahmath BK. Use of Gymnema sylvestre leaf extract in the control of blood in insulin-dependent diabetes mellitus. J Ethnopharmacol 1990; 30: 281-294.
31. Ramos RR, Saenz JLS, Aguilar RJA. Extract of Garcinia cambogia in controlling obesity. Invest Med Int 1995; 22: 97-100.
32. Mattes RD, Bormann L. Effects of (-)-hydroxycitric acid on appetitive variables. Physiol Behav 2000; 71: 87-94.
33. Leonhardt M, Hrupka B, Langhans W. Effect of hydroxycitrate on food intake and body weight regain after a period of restrictive feeding in male rats. Physiol Behav 2001; 74: 191-196.
34. Westerterp-Plantenga MS, Kovacs EMR. The effect of (-)-hydroxycitrate on energy intake and satiety in overweight humans. Int J Obes 2002; 26: 870-872.
35. Ohia SE, Opere CA, LeDay AM, Bagchi M, Bagchi D, Stohs SJ. Safety and mechanism of appetite suppression by a novel hydroxycitric acid extract (HCA-SX). Mol Cell Biochem 2002; 238: 89-103.
36. Loe YC, Bergeron N, Rodriguez N, Schwarz JM. Gas chromatography/mass spectrometry method to quantify blood hydroxycitrate concentration. Anal Biochem 2001; 292: 148-154.
37. Shara MA, Dickson PH, Bagchi D, Stohs SJ. Excretion of formaldehyde, malondialdehyde, acetaldehyde and acetone in the urine of rats in response to 2,3,7,8-tetra-chlorodibenzo-p-dioxin, paraquat, endrin and carbon tetrachloride. J Chromatogr 1992; 576: 221-233.
38. Derelanko MJ. Risk assessment. In: Derelanko MJ, Hollinger MA eds. CRC Handbook of Toxicology. Boca Raton, FL: CRC Press, 1995; 654.
39. Committee for Proprietary Medicinal Products. Note for Guidance on Clinical Investigation of Drugs Used in Weight Control. London, UK: The European Agency for the Evaluation of Medical Products, 1997.
40. Montgomery DC. Design and Analysis of Experiments, 5th edn. New York: Wiley, 2001.
41. Littell RC, Stroup WW, Freund RJ. SAS for Linear Models, 4th edn. Cary, NC: SAS Institute, 2002.
42. Sugerman HJ, Wolfe LG, Sica DA, Clore JN. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 2003; 237: 751-758.
43. Straczkowski M, Kowalska I, Stepien A et al. Insulin resistance in the first-degree relatives of persons with type 2 diabetes. Med Sci Monit 2003; 9: CR186-CR190.
44. Lowenstein JM. Experiments with (-)-hydroxycitrate. In: Burtley W, Komberg HL, Quayle JR eds. Essays in Cell Metabolism. New York, NY: Wiley Interscience, 1970; 153-166.
45. CNN.com.Health. Report: Dietary supplement warning system lacking. Available, from http://www.cnn.com (accessed 25 February 2003).
46. Heymsfield SB, Allison DB, Vasselli JR, Pietrobelli A, Greenfield D, Nunez C. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent. JAMA 1998; 280: 1596-1600.
47. Dagogo-Jack S. Human leptin regulation and promise in pharmacotherapy. Curr Drug Target 2001; 2: 181-195.
48. Adeyemi E, Abdulle A. A comparison of plasma leptin levels in obese and lean individuals in the United Arab Emirates. Nutr Res 2000; 20: 157-166.
49. Lerario DDG, Ferreira SRG, Miranda WL, Chacra AR. Influence of dexamethasone and weight loss on the regulation of serum leptin levels in obese individuals. Braz J Med Biol Res 2001; 34: 479-487.
50. Dhanakoti SN, Draper HH. Response of urinary malondialdehyde to factors that stimulate lipid peroxidation in vivo. Lipids 1987; 22: 643-646.
51. Foster DW. Diabetes mellitus. In: Braunwald E, Isselbacher KJ, Petersdorf RG, Wilson JD, Martin JB, Fauci AS eds. Harrison's Principles of Internal Medicine, 11th edn. New York: McGraw-Hill, 1987; 1778-1796.
52. Winters DK, Clejan LA, Cederbaum AI. Oxidation of glycerol to formaldehyde by rat liver microsomes. Biochem Biophys Res Commun 1988; 153: 612-617.
53. Winters DK, Cederbaum AI. Oxidation of glycerol to formaldehyde by rat liver microsomes. Effects of cytochrome P-450 inducing agents. Biochem Pharmacol 1990; 39: 697-705.
54. Preuss HG, Wallerstedt D, Talpur N et al. Effects of niacin-bound chromium and grape seed proanthocyanidin extract on the lipid profile of hypercholesterolemic subjects: a pilot study. J Med 2000; 31: 227-246.
55. Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 2003; 26: 1277-1294.
56. Ota M, Ariyoshi Y. Location of the disulfide bonds of the sweetness-suppressing polypeptide gurmarin. Biosci Biotechnol Biochem 1995; 59: 1956-1957.